As of 14 Oct 2026, Aureka Biotechnologies has raised $100M across 1 verified round on record; latest: $100 million Series B, announced 10 Aug 2026.
Aureka Biotechnologies develops AI-driven therapeutic discovery technologies to create high-value protein therapeutics for disease treatment.
1 source
The release says a “prominent strategic investor” led a subsequent tranche but does not name it; “nearly US$200 million to date” is cumulative, not this round’s financing total.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M $200M to date | 2026-08-10 | not stated | No recent discussion |
1 source [ VERIFIED · CORRECTED ] read against 1 source The release says a “prominent strategic investor” led a subsequent tranche but does not name it; “nearly US$200 million to date” is cumulative, not this round’s financing total. | ||||